RxDoctor Payments Data

Asokumar Buvanendran

Interventional Pain Medicine · Chicago, ILNPI 1598781676

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $37,193 of the $51,858 with a category attached, or 71.7%. 14 manufacturers reported payments, led by Vertex at 40.5% of the total. Reporting peaked in 2019 at $13,258 and has fallen 88.9% since, to $1,468 in 2025. Among interventional pain medicine clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$51,858in general payments, 2019–2025

Across 271 payments — averaging $191.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertex$21K
  • Medtronic$8K
  • GRT US Holding, Inc.$8K
  • Abbott$5K
  • Fresenius Kabi USA, LLC$5K
  • Pfizer$4K
  • plus $893 from 8 others
$129,915in research payments, 2019–2025

Across 2 payments — averaging $64,958 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Upjohn US 1 LLC$129K
  • Abbott$639

What the payments were for

  • Consulting fees$37,19372%
  • Speaking & faculty fees$6,05012%
  • Travel & lodging$1,6393%
  • Food & beverage$6,94213%
  • Entertainment$340%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Vertex16$20,997
Medtronic(2 entities)85$8,032
GRT US Holding, Inc.1$8,000
Abbott150$5,150
Fresenius Kabi USA, LLC10$5,006
Pfizer1$3,780
Edwards Lifesciences1$450
Pacira Pharmaceuticals Incorporated1$121
Nevro Corp.1$118
Heron Therapeutics, Inc.1$75
SPR Therapeutics, Inc1$58
Smiths Medical ASD, Inc.1$34
Avanos Medical1$20
Curonix LLC1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$51,858 in reported general payments places this provider in the 90th percentile of 93 interventional pain medicine providers in Illinois.

See all interventional pain medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$74,346
Medicare patients
288
Services billed
821

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen71$1,945
Celecoxib50$1,534
Gabapentin81$1,267
Duloxetine Hcl30$894
Baclofen58$512
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$366
Tramadol Hcl68$336
Pregabalin14$204
Meloxicam25$170
Tizanidine Hcl16$153
Cyclobenzaprine Hcl20$136
Cephalexin16$114
Ibuprofen11$103

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →